Breast cancer tumour response to neoadjuvant chemotherapy
A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumours before surgery. These findings could eliminate delays in effective early treatment for tumours unlikely to respond to neoadjuvant chemotherapy (NAC). Breast cancer is […]
